CASSIE CALDER: Open Payments
NPI 1164623138 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 59 payments from 8 companies in 2025. Trend: 2023 $342 · 2024 $1,254 · 2025 $938
Food & beverage: $938
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $665 |
| Janssen Biotech, Inc. | 4 | $99 |
| Aimmune Therapeutics, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| GENZYME CORPORATION | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: RINVOQ, SKYRIZI, TREMFYA, ZENPEP, OMVOH, XIFAXAN, ENTYVIO, DUPIXENT.
Industry payments across TN — which companies pay providers there.
